Gujarat Cancer & Research Institute (GCRI)
Ahmedabad, Gujarat, India
Cancer treatment center in Ahmedabad, Gujarat
M. P. Shah Cancer Hospital Campus, New Civil Hospital Rd, Asarwa, Ahmedabad, Gujarat 380016
About Gujarat Cancer & Research Institute (GCRI)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Gujarat Cancer & Research Institute (GCRI)
During the past decade, Gujarat Cancer & Research Institute (GCRI) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
2003-08-01
2016-12-01
Completed
1,706
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
2004-05-01
2016-05-01
Completed
2,722
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer
2006-02-01
2011-03-01
Terminated
208
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gujarat Cancer & Research Institute (GCRI)" #1 sponsor was "Pfizer" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials
sponsored, "CureTech Ltd" with 1 trials sponsored, "Partha Basu" with 1 trials sponsored and "Tata Memorial Hospital"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gujarat Cancer & Research Institute (GCRI)"
#1 collaborator was "All India Institute of Medical Sciences, New Delhi" with 2 trials as a collaborator, "Basavatarakam Indo- American Cancer Hospital (BIACH)" with 1 trials as a collaborator, "Cancer Foundation of India" with 1 trials as a collaborator, "Christian Fellowship Community Health Centre" with 1 trials as a collaborator and "Deutsches Krebsforschungszentrum (DKFZ)" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at Gujarat Cancer & Research Institute (GCRI)
According to Clinical.Site data, the most researched conditions in "Gujarat Cancer & Research Institute (GCRI)" are
"Advanced Non-Small Cell Lung Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Cervical Cancer" (1 trials), "Cervical Precancerous Lesions" (1 trials) and "Lymphoma, Large Cell, Diffuse" (1 trials). Many other conditions were trialed in "Gujarat Cancer & Research Institute (GCRI)" in a lesser frequency.
Clinical Trials Intervention Types at Gujarat Cancer & Research Institute (GCRI)
Most popular intervention types in "Gujarat Cancer & Research Institute (GCRI)" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "0.5% lignocaine 60mM" (1 trials), "BIBW 2992" (1 trials), "CT-011" (1 trials), "Dacomitinib" (1 trials) and "Lorlatinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gujarat Cancer & Research Institute (GCRI)
The vast majority of trials in "Gujarat Cancer & Research Institute (GCRI)" are
3 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Gujarat Cancer & Research Institute (GCRI)
Currently, there are NaN active trials in "Gujarat Cancer & Research Institute (GCRI)".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Gujarat Cancer & Research Institute (GCRI),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Gujarat Cancer & Research Institute (GCRI), 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".